The skeletal dysplasias are a heterogeneous group of disorders which result in disproportionate short stature and/or skeletal deformities. Although they have long been considered to be generalized disorders of endochondral and/or membranous ossification, the extent of their heterogeneity has only recently been recognized and little is known concerning their pathogenesis. This project is directed toward a multidisciplinary investigation of the clinical, genetic, morphologic, biochemical and molecular characteristics of the skeletal dysplasias.
The specific aims of this proposal will be: (a) expansion and further computerization of the International Skeletal Dysplasia Registry; (b) Definition of the clinical variability and genetic heterogeneity of the skeletal dysplasias; (c) definition of the natural history, growth characteristics and complications of each of these disorders and evaluation of methods for their treatment and management; (d) improvement of methods for their prenatal diagnosis; (e) clinical evaluation of medical and surgical methods of growth promotion; (f) elucidation of the histological, histochemical, immunocytochemical and ultrastructural characteristics of chondro-osseous tissue in each of these disorders; (g) elucidation of their basic biochemical defects by means of biochemical analysis of cartilage and cultured chondrocytes; (h) linkage analysis of individual syndromes with RFLP's of certain candidate genes; and (i) elucidation of their molecular defects by the analysis of collagen and proteoglycan mRNA and DNA. This program project is divided into a core facility - The International Skeletal Dysplasia Registry, plus five separate grant proposals: (1) Clinical and morphological studies; (2) Studies on differentiated chondrocytes in cultures; (3) Collagen biochemistry in the skeletal dysplasias; (4) Molecular studies in the skeletal dysplasias; (5) Analysis of proteoglycans in chondrodysplasias.
|Joeng, Kyu Sang; Lee, Yi-Chien; Lim, Joohyun et al. (2017) Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis. J Clin Invest 127:2678-2688|
|Madan, Simran; Liu, Wei; Lu, James T et al. (2017) A non-mosaic PORCN mutation in a male with severe congenital anomalies overlapping focal dermal hypoplasia. Mol Genet Metab Rep 12:57-61|
|Rajagopal, Abbhirami; Homan, Erica P; Joeng, Kyu Sang et al. (2016) Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice. Mol Genet Metab 117:378-82|
|Xue, Yuan; Schoser, Benedikt; Rao, Aliz R et al. (2016) Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death. Circ Cardiovasc Genet 9:130-5|
|Lietman, Caressa D; Marom, Ronit; Munivez, Elda et al. (2015) A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation. J Bone Miner Res 30:489-98|
|Hudson, David M; Joeng, Kyu Sang; Werther, Rachel et al. (2015) Post-translationally abnormal collagens of prolyl 3-hydroxylase-2 null mice offer a pathobiological mechanism for the high myopia linked to human LEPREL1 mutations. J Biol Chem 290:8613-22|
|Chen, Shan; Grover, Monica; Sibai, Tarek et al. (2015) Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton. Mol Genet Metab 115:53-60|
|Murali, Chaya; Lu, James T; Jain, Mahim et al. (2014) Diagnosis of ALG12-CDG by exome sequencing in a case of severe skeletal dysplasia. Mol Genet Metab Rep 1:213-219|
|Cabral, Wayne A; Perdivara, Irina; Weis, MaryAnn et al. (2014) Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta. PLoS Genet 10:e1004465|
|Tao, Jianning; Jiang, Ming-Ming; Jiang, Lichun et al. (2014) Notch activation as a driver of osteogenic sarcoma. Cancer Cell 26:390-401|
Showing the most recent 10 out of 365 publications